The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience

• Main Authors: D. A. Enaldieva (Author), P. V. Krivorotko (Author), E. N. Imyanitov (Author), E. K. Zhiltsova (Author), R. V. Donskikh (Author), A. P. Sokolenko (Author), L. F. Shaykhelislamova (Author), T. T. Tabagua (Author), L. P. Gigolaeva (Author), A. V. Komyakhov (Author), K. S. Nikolaev (Author), K. Yu. Zernov (Author), S. S. Ereshchenko (Author), R. M. Paltuev (Author), A. A. Bessonov (Author), A. S. Artemyeva (Author), R. S. Pesotskiy (Author), N. S. Amirov (Author), A. S. Emelyanov (Author), V. V. Mortada (Author), Ya. I. Bondarchuk (Author), V. V. Semiglazov (Author), T. Yu. Semiglazova (Author), V. F. Semiglazov (Author), A. M. Belyaev (Author)
• Format: Book
• Published: ABV-press, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in finding new treatment options for patients with this subtype of breast cancer.   Aim. To det...